Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.54 USD | +1.48% | +12.84% | -14.43% |
Sales 2024 * | 293M 23.45B | Sales 2025 * | 354M 28.32B | Capitalization | 1.82B 146B |
---|---|---|---|---|---|
Net income 2024 * | -180M -14.4B | Net income 2025 * | -159M -12.72B | EV / Sales 2024 * | 5.63 x |
Net cash position 2024 * | 173M 13.83B | Net cash position 2025 * | 139M 11.09B | EV / Sales 2025 * | 4.76 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-12
x | Employees | 919 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.22% |
Latest transcript on Twist Bioscience Corporation
1 day | +1.48% | ||
1 week | +12.84% | ||
Current month | -8.07% | ||
1 month | -8.07% | ||
3 months | -2.29% | ||
6 months | +108.74% | ||
Current year | -14.43% |
Managers | Title | Age | Since |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 03/02/13 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 31/03/13 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | 01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 31/10/16 |
Jan Johannessen
BRD | Director/Board Member | 67 | 30/09/18 |
Keith Crandell
BRD | Director/Board Member | 63 | 30/09/13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.68% | 1 M€ | 0.00% | - | |
1.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 31.54 | +1.48% | 644,436 |
25/04/24 | 31.08 | +1.07% | 1,234,632 |
24/04/24 | 30.75 | -2.38% | 1,402,387 |
23/04/24 | 31.5 | +6.96% | 1,065,616 |
22/04/24 | 29.45 | +5.37% | 935,699 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.43% | 1.82B | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- TWST Stock